cdr3.jpg (9069 bytes)



Journal Home
Editorial Board
Instructions for Contributors
Subscription Rates

Neva Press, Inc. 2005

Cardiovascular Drug Reviews

Table of Contents

Volume 16, No. 3

169 A Review of the New Angiotensin II-Receptor Antagonist Irbesartan
James R. Powell, Richard A. Reeves, Maria R. Marino, Catherine Cazaubon and Dino Nisato
195 SP/W-5186:   A Novel Sulfhydryl-Containing NO-Donor
R. Bonn, U. Scharfenecker, H. Friehe and J. Gerloff
212 Nipradilol:   A b-Adrenoceptor Antagonist with Nitric Oxide-Releasing Action
Toshio Hayashi and Akihisa Iguchi
236 Cerivastatin (BAY w 6228):  A Novel HMG-CoA Reductase Inhibitor
J. Kuhlmann, W. Mhck, H. Bischoff, E. von Keutz and M. Llewellyn
264 Overview of the Pharmacological Properties of Daltroban, a Thromboxane A2/Prostanoid-Receptor Partial Agonist
Gareth W. John, Francis C. Colpaert and Jean-Pierre Valentin
288 Tranilast:   A New Application in the Cardiovascular Field as an Antiproliferative Drug
Masayuki Isaji, Hiroshi Miyata and Yukiyoshi Ajisawa
Meeting Reports
300 Cardiovascular Ageing.  Physiology, Pathology, Pharmacology and Therapeutics.  IUPHAR Satellite Symposiu.  Nancy, France.  July 23-24, 1998
J. Atkinson
312 New Cardiovascular Drugs, XIIIth International Congress of Pharmacology.  Munich, Germany.  July 26-31, 1998.
A. Scriabine